Overdrive pacing in quinidine syncope and other long QT-interval syndromes.
Prolongation of QT interval is associated with repetitive paroxysm of a particular ventricular tachycardia. It is a typical complication of quinidine therapy but may occur in various other conditions. We used endocardial pacing in nine patients with prolongation of the QT interval who suffered from bouts of ventricular tachycardia and fibrillation. In six patients, the syndrome was due to quinidine and in three, to prenylamine. Acceleration of heart rate resulted in immediate suppression of all arrhythmias. Pacing was continued until the condition producing the QT prolongation disappeared. In one case, a permanent pacemaker was implanted, as the QT prolongation was congenital and permanent. The absolute QT interval was shortened by overdrive pacing from a mean value of 0.65 s to 0.50 s. The corrected QT interval remained prolonged (about 0.56 s). Thus, the arrhythmia was associated with the duration of the actual QT interval, and overdrive pacing was able to suppress it without shortening the corrected QT interval.
D000328:Adult; D000368:Aged; D001281:Atrial Fibrillation / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy*; D002304:Cardiac Pacing, Artificial; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D011802:Quinidine / Q000009:adverse effects*; D013575:Syncope / Q000139:chemically induced / Q000628:therapy*; D013577:Syndrome; D013610:Tachycardia / Q000139:chemically induced / Q000175:diagnosis / Q000628:therapy*
D011802:Quinidine